Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

THNR ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

THNR Analyst Ratings

Moderate Buy
18ConsensusRatings
17Buy1Hold0Sell
Based on the Wall Street analyst consensus for 18 of THNR’s holdings.

THNR 12 Month Forecast

$34.66▲(40.33% Upside)
Based on Wall Street analyst 12-month price targets for 18 of Amplify Weight Loss Drug & Treatment ETF’s holdings in the last 3 months. The average price target is $34.66 with a high forecast of $42.40 and a low forecast of $24.73. The average price target represents a 40.33% change from the last price of $24.70.
Highest Price Target$42.40Average Price Target$34.66Lowest Price Target$24.73

THNR Stocks With Highest Upside Potential

THNR highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$108.46(411.85% Upside)
Strong Buy$91.71(275.84% Upside)
Strong Buy$45.00(250.19% Upside)
Strong Buy$109.00(87.87% Upside)
Strong BuyHK$80.14(67.80% Upside)

THNR Stocks With Highest Downside Potential

THNR highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Moderate Buy$405.42(-7.70% Downside)
Moderate Buy$29.62(-1.37% Downside)
Moderate BuyCHF388.77(-0.54% Downside)
Strong Buy$293.50(2.75% Upside)
Strong Buy$160.80(3.05% Upside)

THNR ETF FAQ

What is THNR’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 18 of THNR’s holdings, Amplify Weight Loss Drug & Treatment ETF’s 12-month average price target is $34.66.
What is THNR’s upside potential, based on the analysts’ average price target?
THNR’s average price target of $34.66 represents a 40.33% upside from its last price of $24.70.
Is THNR a Buy, Sell or Hold?
Amplify Weight Loss Drug & Treatment ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 18 of THNR’s holdings: 17 rated Buy, 1 rated Hold and 0 rated Sell.
What is Amplify Weight Loss Drug & Treatment ETF’s price target?
The average price target for Amplify Weight Loss Drug & Treatment ETF is $34.66, based on Wall Street analyst 12-month price targets for 18 of THNR’s holdings, issued in the past 3 months. The highest price target is $42.40 and the lowest is $24.73. The average price target represents a 40.33% increase from the last price of $24.70.
What is THNR’s expense ratio?
THNR’s expense ratio is 0.59%.
How many holdings does THNR have?
THNR holds 22 assets.
How can I buy shares of THNR?
You can buy shares of THNR through a brokerage account. Compare brokers on our Best Online Brokers page.